Revenue segments as reported by the company.

Clearing and transaction fees

Market data and information services

Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Compensation and benefits  

Technology

Professional fees and outside services

Amortization of purchased intangibles

Depreciation and amortization

Licensing and other fee agreements

Other expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CME Group achieves record-breaking 2022 performance amidst market challenges

CME Group's 2022 performance was exceptional, marked by record volumes, revenue growth, and successful transitions. The company's focus on innovation, strategic positioning in energy and cryptocurrency markets, and pricing adjustments have driven positive outcomes. Challenges in margins and market uncertainties require careful navigation.

CME Group posts record Q1 earnings, eyes growth in SOFR

CME Group delivered a strong performance in Q1 2023, achieving record revenue and profitability driven by growth in interest rate and options trading.
The company's strategic focus on risk management, shareholder value creation, and market competitiveness positions it well for future growth and revenue generation.
While facing challenges in a competitive market environment, CME Group has opportunities to capitalize on the demand for SOFR products and options trading.
Optimism surrounding the company's future growth potential, coupled with effective expense management and revenue diversification, underpin its resilience and strategic outlook.

CME Group excels in Q2 with record revenue and strategic focus

CME Group's Q2 earnings call showcased strong financial performance, driven by growth across asset classes and a focus on customer-centric strategies. The company's emphasis on innovation, regulatory compliance, and market leadership positions it well for future growth.

CME Group reports strong Q3 earnings, eyes growth amid challenges

CME Group's Q3 2023 earnings call highlighted robust financial performance, operational efficiency, and strategic positioning. Despite facing regulatory challenges and cost management concerns, the company remains confident in its offerings and growth prospects. Opportunities for expansion through innovation and capitalizing on market trends were key discussion points.

CME Group achieves record 2023 results amidst global uncertainties

CME Group's record-breaking performance in 2023 underscores its market leadership and financial strength, with revenue growth, margin expansion, and strong product demand driving positive results.
While facing challenges from global uncertainties and market dynamics, the company's strategic focus on innovation, risk management, and efficiency positions it well to capitalize on opportunities in evolving markets.
By introducing new products, expanding partnerships, and navigating changing market conditions adeptly, CME Group demonstrates resilience and adaptability, paving the way for continued growth and success in the financial industry.
Overall, CME Group's strategic initiatives, financial performance, and market positioning reflect a company poised for sustained success, leveraging opportunities and strengths to overcome challenges and drive future growth.

CME Group achieves record earnings in Q1 2024, eyes growth

CME Group delivered a strong performance in Q1 2024, setting records in revenue and earnings.
The company faces challenges in managing expenses amid growth initiatives and competitive dynamics.
However, CME's strengths in market leadership, network infrastructure, and regulatory alignment position it well for future opportunities.
By capitalizing on data services and revenue growth avenues, CME can continue its upward trajectory in the market.

CME Group achieves record Q3 performance amidst regulatory challenges

CME Group's Q3 performance was exceptional, marked by record volumes and financial metrics. Despite challenges in regulatory compliance and competition, the company is well-positioned for growth through strategic opportunities in interest rate products and retail expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CME Group (CME) Q3 results reflect higher clearing and transaction fees, increased market data and information services revenues, and lower expenses as well as an increase in average daily volume in two of the six products lines.

CME Group (CME) Q3 Earnings Top Estimates, Revenues Rise Y/Y

CME (CME) delivered earnings and revenue surprises of 3.23% and -3.18%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

CME Group (CME) Surpasses Q3 Earnings Estimates

Futures exchange operator CME Group Inc said on Wednesday its third-quarter profit had more than doubled, spurred by robust trading across a majority of its asset classes.

Exchange operator CME's quarterly profit jumps 125%

CHICAGO, Oct. 27, 2021 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2021. The company reported revenue of $1.1 billion and operating income of $614 million for the third quarter of 2021.

CME Group Inc. Reports Third-Quarter 2021 Financial Results

CME Group is scheduled to report its fiscal Q3 2021 results on Wednesday, October 27. We expect CME Group to beat the earnings and revenue consensus estimates.

Earnings Beat In The Cards For The CME Group Stock In Q3?

CME Group's third-quarter revenues are likely to have been aided by clearing, transaction fees and other revenues, and market data and information services.

What's in the Offing for CME Group (CME) in Q3 Earnings?

CHICAGO, Oct. 21, 2021 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today announced that a record 396,421 SOFR futures contracts were traded on October 18, 2021, surpassing the previous record of 341,922 contracts set on June 18, 2021. SOFR futures open interest continues to grow as well, reaching a record 1,166,016 contracts on October 19, 2021, up 170% and growing 16% in one month, having surpassed one million contracts of open interest on September 15, 2021.

CME Group Announces Record SOFR Futures Volume and Open Interest

LONDON and SINGAPORE, Oct. 13, 2021 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today announced that its international average daily volume (ADV) reached 5 million contracts in Q3 2021, up 13% year on year. Reflecting all trading done outside the United States, volume increases were driven by global growth in Interest Rate and Energy products, up 54% and 31% respectively.

CME Group International Average Daily Volume Reached 5 Million Contracts in Q3 2021, Up 13% from Q3 2020

CME Group (CME) holds potential to reap benefits driven by expansion of futures products, strong global presence, prudent capital deployment and sufficient liquidity position.

CME Group (CME) Futures Products Aid Amid Cost Concerns

CME Group's (CME) Q3 average daily volumes reflect higher volumes in two of the six product lines.

CME Group (CME) Q3, September Volumes Up in Two Product Lines

CHICAGO, Oct. 4, 2021 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today reported its Q3 and September 2021 market statistics, showing average daily volume (ADV) increased 14 percent to 17.8 million contracts during the third quarter, and was up 11 percent at 18.8 million contracts during the month of September. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume.

CME Group Reports Q3 and September 2021 Monthly Market Statistics

CME Group stock, the world's largest financial derivatives exchange, has improved 5.5% in the last week. But will the company's stock continue to rise over the coming weeks, or is a decline in the stock price imminent?

What's Next For CME Group Stock After Its 5.5% Rise In A Week?

Advanced Micro Devices

Coinbase

JPMorgan Chase & Co

PayPal

Riot Blockchain

Silvergate Capital Corp

These top crypto stocks are among the premier options for investors looking at ways to play the surging cryptocurrency space. The post 7 Crypto Stocks to Buy to Honor Bitcoin's New Legal Tender Status appeared first on InvestorPlace.

7 Crypto Stocks to Buy to Honor Bitcoin's New Legal Tender Status

Assurant

AMERISAFE

American Tower

Anthem

Auburn National Bancorporation

Broadcom

Avnet

Bank of America

Blackrock Inc

Commerce Bancshares

Capital City Bank Group

CNO Financial Group

CyrusOne

Dick's Sporting Goods

Equity LifeStyle Properties

Equinix

Exponent

Fifth Third Bancorp

Farmers & Merchants Bancorp

First Midwest Bancorp

Federal Realty Investment Trust

Genpact

Gladstone Investment

weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends.

Dividend Champion Highlights: Week Of September 19

CME Group stock has gained a meager 4% YTD, and at its current price of $189 per share, it is trading 13% below its fair value of $216 – Trefis' estimate for CME Group's valuation. The stock has lost approximately 11% since its second-quarter 2021 results in July, despite outperforming the.

CME Group Stock Is Trading 13% Below Its Fair Value

CHICAGO, Sept. 15, 2021 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today announced it will launch E-mini Russell 2000 Monday and Wednesday Weekly options on October 4, pending regulatory review.

CME Group to Launch E-mini Russell 2000 Monday and Wednesday Weekly Options on October 4

CHICAGO, Sept. 10, 2021 /PRNewswire/ -- CME Group Inc. will announce earnings for the third quarter of 2021 before the markets open on Wednesday, October 27, 2021.

CME Group Inc. Announces Third-Quarter 2021 Earnings Release, Conference Call

Intercontinental Exchange

Let's see how CME Group (CME) and Intercontinental Exchange (ICE) fare in terms of some of the key metrics.

ICE or CME: Which Securities & Exchanges Stock Has an Edge?

Automatic Data Processing

Ecolab

Coca-Cola

Merck

UnitedHealth Group

We provide a summary of upcoming ex-dividend dates in a quick reference table. The table includes relevant data and key statistics as well as the next payout and pay date.

Upcoming Ex-Dividend Dates: September 7-20, 2021

CME is now lapping the easiest compares from mid 2020. Tighter monetary policy and higher stock market volatility typically results in stronger volume at CME.

CME Group: Hold For Easier Compares, Return Of Higher Rates And Market Volatility

CME Group's (CME) average daily volume of 17.5 million contracts per day increases 7% year over year due to higher volumes in three of the six product lines.

CME Group (CME) August ADV Increases at Three Product Lines

CHICAGO, Sept. 2, 2021 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today reported August 2021 market statistics, including average daily volume (ADV) of 17.5 million contracts during the month.

CME Group Reports August 2021 Monthly Market Statistics

Harbor PanAgora Dynamic Large Cap Core ETF

CME Group Inc (NASDAQ: CME) and IHS Markit Ltd (NYSE: INFO) launched a joint venture, OSTTRA, a provider of post-trade solutions for the global OTC markets across interest rate, FX, equity, and credit asset classes. IHS Markit paid a $113 million equalization payment to CME Group to achieve 50/50 ownership and shared control in the joint venture.

CME Group, IHS Markit Launch Post-Trade Services Company 'OSTTRA'

LONDON and CHICAGO , Sept. 1, 2021 /PRNewswire/ -- CME Group (NASDAQ: CME), the world's leading and most diverse derivatives marketplace, and IHS Markit (NYSE: INFO), a world leader in critical information, analytics and solutions, today announced they have launched their joint venture, OSTTRA, a new post-trade services company.

CME Group and IHS Markit Complete Joint Venture and Launch OSTTRA, a New Post-Trade Services Company

CHICAGO , Aug. 30, 2021 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today announced that more than 1 billion Micro futures and options contracts have been traded to date. "Retail participation across CME Group continued to grow during the first half of the year, and our innovative, Micro-sized products help ensure that both individual and institutional clients can even more easily access our markets going forward," said Julie Winkler, CME Group Chief Commercial Officer.

News for CME Group Stock (CME)